[ Price : $8.95]
Federal Register notice: FDA seeks comments concerning recommendations by the World Health Organization to impose international ma...[ Price : $8.95]
Philips North America recalls its BrightView computed tomography gamma camera system because of the risk of the detector unexpecte...[ Price : $8.95]
FDA sets a 10/8 PDUFA action date for a Bristol Myers Squibb sNDA for Opdivo to treat some non-small cell lung cancers.[ Price : $8.95]
Amneal Pharmaceuticals resubmits an NDA for IPX203, a novel oral formulation of carbidopa/levodopa extended-release capsules for t...[ Price : $8.95]
Four Hogan Lovells attorneys say medical device companies should begin now to prepare for the implementation of FDAs new Quality M...[ Price : $8.95]
Office of Generic Drugs associate director of stakeholder and global engagement Sarah Ibrahim says FDA and EMA are evaluating a ne...[ Price : $8.95]
Gilead Sciences discontinues its Phase 3 ENHANCE-3 study of magrolimab in acute myeloid leukemia (AML) after FDA placed a clinical...[ Price : $8.95]
Federal Register notice: FDA posts a listing of six information collections that have been approved by OMB.